Dr Reddy's recalls some Paricalcitol capsules from US market

Dr Reddy's Laboratories has started recalling some lots of its Paricalcitol Capsules of 1 mcg, 2 mcg 4 mcg strengths from the US market voluntarily due to "reports of breakage and leakage of" the capsules.
According to a notification put by the US Food and Drug Administration, these lots are recalled under 'Class-III' classification which was described as 'a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences'.
Paricalcitol, a Vitamin-D compound is used for preventing and treating high levels of parathyroid hormone in certain patients with chronic kidney disease.

As per the notification, the firm is recalling 24,661 bottles from the market from November last year.
These capsules are manufactured at DRL's Bachupally unit in Hyderabad.
Dr Reddy's shares today closed at Rs 2,992.20, down 0.01 per cent on BSE.